The Food and Drug Administration FDA announces a forthcoming public advisory committee meeting of the Digital Health Advisory Committee the Committee. The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The Committee will discuss total product lifecycle considerations for Generative Artificial Intelligence AI-enabled devices. The meeting will be open to the public. FDA is establishing a docket for public comment on this topic.